Structure and Functions of Hepatitis C Virus Proteins: 15 Years After

Overview

Journal Folia Microbiol (Praha)

Publisher Springer

Specialty Microbiology

Date 2007 Apr 26

PMID 17455808

Citations 8

Authors

L Krekulova

V rehak

L W Riley

Affiliations

Soon will be listed here.

Abstract

Since its discovery in 1988, the hepatitis C virus (HCV) has become a hot topic of research by many groups around the world. This globally spread infectious agent is responsible for a large proportion of chronic viral hepatitides. The clue to halting the hepatitis C pandemic may be the detailed understanding of the virus structure, its replication mechanism, and the exact functions of the various proteins. Such understanding could enable the development of new antivirals targeted against hepatitis C virus and possibly an effective vaccine. This review recaps the current knowledge about the HCV genome 15 years after its discovery. The structure and function of particular viral structural (core, E1, E2) and nonstructural (NS2, NS3, NS4, NS5) proteins and noncoding regions known to date are described. With respect to frequent conflicting reports from different research groups, results reproducibly demonstrated by independent investigators are emphasized. Owing to many obstacles and limitations inherent in doing research on this noteworthy virus, the current knowledge is incomplete and the answers to many important questions are to be expected in the future.

Citing Articles

Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt.

Shoun A, Abozahra R, Baraka K, Mehrez M, Abdelhamid S Microorganisms. 2022; 10(4).

PMID: 35456731 PMC: 9024585. DOI: 10.3390/microorganisms10040679.

Novel hepaci- and pegi-like viruses in native Australian wildlife and non-human primates.

Porter A, Pettersson J, Chang W, Harvey E, Rose K, Shi M Virus Evol. 2020; 6(2):veaa064.

PMID: 33240526 PMC: 7673076. DOI: 10.1093/ve/veaa064.

Interaction of viral oncogenic proteins with the Wnt signaling pathway.

Khanizadeh S, Hasanvand B, Lashgarian H, Almasian M, Goudarzi G Iran J Basic Med Sci. 2018; 21(7):651-659.

PMID: 30140402 PMC: 6098952. DOI: 10.22038/IJBMS.2018.28903.6982.

Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A.

Shier M, El-Wetidy M, Ali H, Al-Qattan M Saudi J Gastroenterol. 2016; 22(3):240-8.

PMID: 27184644 PMC: 4898095. DOI: 10.4103/1319-3767.182461.

Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients.

Sadri M, Farajollahi M, Sharifi Z Iran J Basic Med Sci. 2015; 18(2):159-63.

PMID: 25810890 PMC: 4366727.

References

Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C . Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol. 1998; 72(5):3691-7. PMC: 109590. DOI: 10.1128/JVI.72.5.3691-3697.1998. View

Boyer J, Haenni A . Infectious transcripts and cDNA clones of RNA viruses. Virology. 1994; 198(2):415-26. DOI: 10.1006/viro.1994.1053. View

Kurosaki M, Enomoto N, Marumo F, Sato C . Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology. 1993; 18(6):1293-9. View

Owsianka A, Patel A . Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology. 1999; 257(2):330-40. DOI: 10.1006/viro.1999.9659. View

Ferrari E, Fang J, Baroudy B, Lau J, Hong Z . Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J Virol. 1999; 73(2):1649-54. PMC: 103993. DOI: 10.1128/JVI.73.2.1649-1654.1999. View

Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C . Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med. 1996; 334(2):77-81. DOI: 10.1056/NEJM199601113340203. View

Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A . Internal ribosome entry site within hepatitis C virus RNA. J Virol. 1992; 66(3):1476-83. PMC: 240872. DOI: 10.1128/JVI.66.3.1476-1483.1992. View

Griffin S, Harvey R, Clarke D, Barclay W, Harris M, Rowlands D . A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol. 2004; 85(Pt 2):451-461. DOI: 10.1099/vir.0.19634-0. View

Kolykhalov A, Feinstone S, Rice C . Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA. J Virol. 1996; 70(6):3363-71. PMC: 190207. DOI: 10.1128/JVI.70.6.3363-3371.1996. View

10.

Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T . Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A. 1990; 87(24):9524-8. PMC: 55204. DOI: 10.1073/pnas.87.24.9524. View

11.

Zhao W, Wimmer E, Lahser F . Poliovirus/Hepatitis C virus (internal ribosomal entry site-core) chimeric viruses: improved growth properties through modification of a proteolytic cleavage site and requirement for core RNA sequences but not for core-related polypeptides. J Virol. 1999; 73(2):1546-54. PMC: 103979. DOI: 10.1128/JVI.73.2.1546-1554.1999. View

12.

Lohmann V, KORNER F, Herian U, Bartenschlager R . Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol. 1997; 71(11):8416-28. PMC: 192304. DOI: 10.1128/JVI.71.11.8416-8428.1997. View

13.

Tanaka T, Kato N, Cho M, Shimotohno K . A novel sequence found at the 3' terminus of hepatitis C virus genome. Biochem Biophys Res Commun. 1995; 215(2):744-9. DOI: 10.1006/bbrc.1995.2526. View

14.

Gale Jr M, Korth M, Tang N, Tan S, Hopkins D, Dever T . Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology. 1997; 230(2):217-27. DOI: 10.1006/viro.1997.8493. View

15.

Simmonds P . The origin and evolution of hepatitis viruses in humans. J Gen Virol. 2001; 82(Pt 4):693-712. DOI: 10.1099/0022-1317-82-4-693. View

16.

Tanji Y, Kaneko T, Satoh S, Shimotohno K . Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol. 1995; 69(7):3980-6. PMC: 189129. DOI: 10.1128/JVI.69.7.3980-3986.1995. View

17.

Bartenschlager R, Lohmann V . Replication of hepatitis C virus. J Gen Virol. 2000; 81(Pt 7):1631-48. DOI: 10.1099/0022-1317-81-7-1631. View

18.

Lunel F . Hepatitis C virus and autoimmunity: fortuitous association or reality?. Gastroenterology. 1994; 107(5):1550-5. DOI: 10.1016/0016-5085(94)90564-9. View

19.

Wang C, Sarnow P, Siddiqui A . Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol. 1993; 67(6):3338-44. PMC: 237677. DOI: 10.1128/JVI.67.6.3338-3344.1993. View

20.

Chang J, Yang S, Cho Y, Hwang S, Hahn Y, Sung Y . Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol. 1998; 72(4):3060-5. PMC: 109754. DOI: 10.1128/JVI.72.4.3060-3065.1998. View